Clinical observation of oxcarbazepine suspension monotherapy for 2 to 4-year-old patients newly diagnosed as partial epilepsy

Chinese Journal of Neurology

Volumn 45, Issue 10, 2012, Pages 730-733

  Chen, Yin Bo ^a   Wang, Jiang Tao ^a   Wang, Li Jun ^a   Liang, Dong ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Carbamazepine; Epilepsies, partial; Treatment outcome

Indexed keywords

CARBAMAZEPINE; OXCARBAZEPINE;

ANTICONVULSANT THERAPY; ARTICLE; CHILD; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FOCAL EPILEPSY; HUMAN; MONOTHERAPY; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

EID: 84867703622     PISSN: 10067876     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1006-7876.2012.10.009     Document Type: Article

References (10)

1. 2011, 44: 56-65.
2. 2010: 384-391.
3. Bares G, Walker E B, Elqer C E, et al. Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy. Epilepsia, 2000, 41: 1597-1607.
4. 2011: 712-715.
5. 2011, 44: 6-9.
6. Kothare S V, Khurana D S, Mostofi N, et al. Oxcarbazepine monotherapy in children and adolescents: a single-center clinical experience. Pediatr Neurol, 2006, 35: 235-239.
7. Rey E, Bulteau C, Motte J, et al. Oxcarbazepine pharmacokinetics and tolerability in children with inadequately controlled epilepsy. J Clin Pharmaco, 2004, 44: 1290-1300.
8. Schmidt D, Sachdeo R. Oxcarbazepine for treatment of partial epilepsy: a review and recommendations for clinical use. Epilepsy Behav, 2000, 1: 396-405.
9. Bourgeois B F, D'Souza J. Long-term safety and tolerability of oxcarbazepine in children: a review of clinical experience. Epilepsy Behav, 2005, 7: 375-382.
10. Franzoni E, Garone C, Sarajlija J, et al. Open prospective study on oxcarbazepine in epilepsy in children: a preliminary report. Seizure, 2006, 15: 292-298.